4:15pm - 4:30pmID: 106
/ TOM4 S5: 1
TOM 4 BioPhotonics and Biosensors
Advancing optical coherence tomography through opto-electronic frequency shifting
Dorian Robert Urban1,2, Pavel Novak2, Miguel Preciado2, Tom Vettenburg1
1University of Dundee; 2Optos plc
Optical Coherence Tomography (OCT) stands out for its ability to combine the high resolution of
microscopy with the penetration-depth of clinical imaging. However, in practice this is still limited to a few
millimetres. Interestingly, the imaging-depth of the latest swept-source systems is not limited by their spectral
width but by the analog-to-digital sampling rate. In lieu of slow reference arm length adjustments, we leverage
opto-electronic frequency shifting. This allows for depth adjustments on the microsecond timescale and a modest
detector bandwidth of 200 MHz . The opto-electronic scheme immediately gives us access to an 8 mm range,
a fourfold increase over the nominal 2 mm range of the source. Moreover, by circumventing the need for a
mechanical reference arm, changes in the axial displacement of the sample can be compensated in real-time.
This makes it attractive for imaging arbitrarily-curved surfaces. We showcase this with wide-field OCT imaging
of the curved retina.
4:30pm - 4:45pmID: 385
/ TOM4 S5: 2
TOM 4 BioPhotonics and Biosensors
Delineation of fresh gastrointestinal tumor biopsies using a fiber-based fluorescence lifetime imaging probe
Dafne Suraci1, Luca Tirloni2, Enrico Baria3, Joao Lagarto4, Serena Pillozzi5, Lorenzo Antonuzzo6,7, Antonio Taddei2,6, Riccardo Cicchi1,8
1National Institute of Optics, National Research Council; 2Hepatobiliopancreatic Surgery, Careggi University Hospital; 3Department of Physics, University of Florence; 4Biophotonics Platform, Champalimaud Foundation; 5Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence; 6Department of Experimental Clinical Medicine, University of Florence; 7Clinical Oncology Unit, Careggi University Hospital; 8European Laboratory for Non-linear Spectroscopy (LENS)
Autofluorescence spectroscopy has emerged in recent years as a powerful tool to report label-free contrast between normal and diseased tissues. In particular, Fluorescence Lifetime Imaging Microscopy (FLIM) has shown detailed profiles of tissue autofluorescence, enabling more informed and rapid tissue characterization, with the potential for translation from the research labs to bedside. We report here the test of our autofluorescence lifetime imaging probe device on four different clinical cases. More in detail, we examined four biopsies, one from a hepatocellular carcinoma (HCC), another from an intrahepatic cholangiocarcinoma (ICC), one from a gastrointestinal stromal tumor (GIST) and the last one from pancreatic ductal adenocarcinoma (PDCA). The results suggest that our autofluorescence lifetime imaging probe, together with phasor analysis, can offer a real-time tool to observe spectral and lifetime contrast on fresh tissues and, thus, is a suitable candidate for improving in situ tissue diagnostics during surgery.
4:45pm - 5:00pmID: 182
/ TOM4 S5: 3
TOM 4 BioPhotonics and Biosensors
Analysis of imaging modalities for classification of tumoral vs. normal tissues using an FD-FLIM based MMF endoscopy probe
Victoria Alexandrine Fay
Laboratory of Applied Photonics Devices, Switzerland
Current surgical resections for Head and Neck Cancers aim for clear margins to prevent local recurrence. However, up to 20% of cases result in positive margins, with secondary surgery increasing the chances of death after 5 years. We envision a MMF endoscope that collects high resolution images using wavefront shaping to scan a 405 nm beam at the fiber tip and collecting fluorescence intensity and lifetime to map tumor margins and detect residual malignant cells. To address the question whether the information contained in the fluorescence and morphology can be used to classify cancer and normal tissues, we used images acquired with a microscope and artificial neural network. Initial findings show promise to separate cancer from normal tissue when training neural networks on FLIM data. Spatial and temporal resolution and required field of view for effective margin assessment are determined.
5:00pm - 5:15pmID: 201
/ TOM4 S5: 4
TOM 4 BioPhotonics and Biosensors
Side-scattering spectroscopy of biological aggregates
Zita Salajkova1,2, Lorenzo Barolo3, Paola Baiocco3, Barbara Ruzicka4, Alberto Boffi1,3, Vincenzo Ricco2, Giancarlo Ruocco1,4, Marco Leonetti2,5
1Center for Life Nano- and Neuro-Science, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161, Rome, Italy; 2D-TAILS srl, Via di Torre Rossa, 66, 00165, Rome, Italy; 3Department of Biochemical Sciences “Alessandro Rossi Fanelli”, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy.; 4Department of Physics, Sapienza University of Rome, Piazzale Aldo Moro, 5, 00185, Rome, Italy; 5Institute of Nanotechnology of the National Research Council of Italy, CNR-NANOTEC, Rome Unit, Piazzale A. Moro 5, I-00185, Rome, Italy
In this study, we introduce a novel optical setup tailored for measuring scattering spectra of small biological aggregates with minimal sample volumes. Calibration was achieved using Polystyrene beads (PS beads) based on Mie scattering principles, enabling accurate measurements of scattering intensities. Bovine serum albumin (BSA) served as a model for studying protein aggregation due to its predictable aggregation behaviour at elevated temperatures. Analysis of non-aggregated and aggregated BSA solutions revealed significant differences in particle size, underscoring the setup's capability to detect variations in aggregation states. Key findings demonstrate the system's efficacy in monitoring protein aggregation processes, which is critical for biochemical and pharmaceutical research. The precise calibration method and the use of BSA as a validation tool highlight the setup's sensitivity and accuracy in quantifying changes in particle concentration and size due to aggregation. This study provides a framework for analysing protein aggregation and offers insights into the aggregation's impact on scattering properties.
5:15pm - 5:30pmID: 312
/ TOM4 S5: 5
TOM 4 BioPhotonics and Biosensors
Raman and Polarization-sensitive digital holographic imaging for rapid and label-free prostate cancer diagnosis
Hossein Khadem1, Maria Antonietta Ferrara2, Maria Mangini1, Alberto Luini1, Giuseppe Coppola2, Anna Chiara De Luca1
1Institute for the Experimental Endocrinology and Oncology “G. Salvatore”, Secondary Unit, National Research Council, Naples, Italy; 2Institute of Applied Sciences and Intelligent Systems, National Research Council, Naples, Italy
In this study, we report the results of two non-invasive optical methods, Raman microscopy (RM) and polarization-sensitive digital holographic imaging (PSDHI), for distinguishing prostate cancer cells from healthy ones. RM reveals cancer cells metabolize glucose faster, storing it as fatty acids and cholesteryl esters in lipid droplets (LDs). On the other hand, PSDHI shows significant morphological changes in LDs in glucose-incubated cancer cells, including number, volume, and refractive index. High birefringence in cancer LDs under perpendicular polarizations was observed, enabling fast discrimination with over 90% accuracy. PSDHI results align closely with Raman microscopy, suggesting its potential as a promising, high-speed technique for cancer screening purposes.
5:30pm - 5:45pmID: 379
/ TOM4 S5: 6
TOM 4 BioPhotonics and Biosensors
Evolution of the optical scattering properties of blood plasma during clot formation
Lea Abi nassif1, Wadih Khater1,3, Fabrice Pellen1, Bernard Le jeune1, Marie Abboud2, Benjamin Espinasse3, Guy Le brun1
1Laboratoire OPTIMAG, Université de Bretagne Occidentale - UBO, France; 2Université Saint Joseph - USJ, Liban; 3GETBO, Université de Bretagne Occidentale - UBO, France
Venous thromboembolism (VTE) is a common and serious disease which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is created when a blood clot forms in the deep veins of the leg and when the clot migrates through the bloodstream, to lung arteries, it creates a PE. VTE is the third cardiovascular cause of death overall and is responsible for 30000 annual deaths in Europe. After biological and clinical investigation, nearly half of VTE cases have no known origin (idiopathic VTE). Among the patients developing idiopathic VTE, about 30% of them would have a recurrent thromboembolic event, 70% would not be subjected to any recurrence. A balance must be struck between the risks of recurrent thrombosis if anticoagulant treatment is stopped versus the risks of bleeding associated with continued anticoagulation therapy that can go up to the course of decades. The search for new biomarkers allowing to best stear the treatment of patients is thus of major interest. Recent studies seem to link clot’s structure to a risk of recurrence. The aim of our work is to develop an innovative optical method, measuring the evolution of the scattering coefficient of a plasma during ex vivo clot formation.
|